Zimmer Biomet Holdings (ZBH) Capital Expenditures (2009 - 2026)

Zimmer Biomet Holdings has reported Capital Expenditures for 18 years, with the latest figure at $54.2 million in Q2 2026.

• On a quarterly basis, Capital Expenditures rose 8.18% year-over-year to $54.2 million in Q2 2026; TTM through Jun 2026 was $220.3 million, a 15.52% increase from a year earlier, with the FY2025 full-year figure at $224.5 million, up 10.16% from the prior year.
• Capital Expenditures was $54.2 million for Q2 2026 at Zimmer Biomet Holdings, up from $36.3 million in the prior quarter.
• The five-year high for Capital Expenditures was $97.3 million in Q2 2023, with the low at $36.3 million in Q1 2026.
• Average Capital Expenditures over 5 years is $55.4 million, with a median of $52.1 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Capital Expenditures surged 137.9% in 2023, then tumbled 47.21% in 2024.
• Over 5 years, Capital Expenditures stood at $63.4 million in 2022, then dropped by 0.95% to $62.8 million in 2023, then slipped by 17.99% to $51.5 million in 2024, then jumped by 45.24% to $74.8 million in 2025, then fell by 27.54% to $54.2 million in 2026.
• The last three Capital Expenditures figures came in at $54.2 million (Q2 2026), $36.3 million (Q1 2026), and $74.8 million (Q4 2025), per Business Quant data.